CCO Infectious Disease Podcast

Treatment of Skin and Soft Tissue Infections

Episode Summary

Listen as Kyle Molina, PharmD, BCIDP, discusses guideline recommendations for treatment of both purulent and nonpurulent skin and soft tissue infections, challenges with IV and oral antibiotics, and the role of long-acting lipoglycopeptides in the treatment landscape

Episode Notes

In this episode, Kyle Molina, PharmD, BCIDP, provides an overview of treatment of skin and soft tissue infections (SSTIs) and challenges in practice. Listen as he gives perspectives on:

• Guideline recommendations for treatment of purulent and nonpurulent SSTIs
• Logistical challenges with IV and oral antibiotics
• Pros and cons of various locations of care
• Data supporting the safety and efficacy of long-acting lipoglycopeptides for treatment of SSTIs
• Use of long-acting lipoglycopeptides in special populations of interest, including patients with obesity, diabetes, and injection drug use
• Overall place in therapy of long-acting lipoglycopeptides for SSTIs

Faculty:

Kyle Molina, PharmD, BCIDP
Infectious Diseases Clinical Pharmacist
Scripps Green Hospital
La Jolla, California

Link to full program: 

• CCO: https://bit.ly/3J4mg8h
• ProCE: https://bit.ly/3P0vB4E